RxDoctor Payments Data

Alexander Goldin, MD

Otolaryngology/Facial Plastic Surgery · Park Ridge, ILNPI 1518967827

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Medtronic at 37.3% of the total. 2025 is the largest year on record at $161, 9.6 times the $17 reported in 2019. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in IL, where the typical reported total is $914.

$354in general payments, 2019–2025

Across 11 payments — averaging $32.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$132
  • Inspire Medical Systems, Inc.$90
  • Sanofi$71
  • Johnson & Johnson$28
  • Brainlab, Inc.$17
  • Itamar Medical Inc$16

What the payments were for

  • Food & beverage$354100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$354 in reported general payments places this provider in the 15th percentile of 23 otolaryngology/facial plastic surgery providers in Illinois.

See all otolaryngology/facial plastic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$374,249
Medicare patients
1,006
Services billed
2,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl173$5,602
Olopatadine Hcl56$4,942
Ipratropium Bromide183$4,859
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth19$2,415
Fluocinolone Acetonide Oil35$1,320
Fluticasone Propionate79$1,050
Mometasone Furoate35$788
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort17$730
Montelukast Sodium73$670
Omeprazole35$510
Pilocarpine Hcl11$480
Prednisone33$405
Amitriptyline Hcl36$338
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$233
Celecoxib20$216

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Park Ridge

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →